A business in context
CORT research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-08-25 | Maduck Sean | S · Sale | Common Stock | 5870.0 | 126.06 |
| 2026-08-25 | Maduck Sean | M · Exercise / conversion | Common Stock | 30955.0 | 11.35 |
| 2026-08-25 | Maduck Sean | S · Sale | Common Stock | 25085.0 | 125.47 |
| 2026-08-25 | Maduck Sean | M · Exercise / conversion | Stock option (right to buy) | 30955.0 | 0.0 |
| 2026-08-18 | MAHONEY DAVID L | S · Sale | Common Stock | 91167.0 | 118.24 |
| 2026-08-18 | MAHONEY DAVID L | S · Sale | Common Stock | 400.0 | 119.64 |
| 2026-08-18 | MAHONEY DAVID L | S · Sale | Common Stock | 7055.0 | 118.88 |
| 2026-08-18 | MAHONEY DAVID L | S · Sale | Common Stock | 4984.0 | 117.47 |
| 2026-08-17 | Robb Gary Charles | G · Gift | Common Stock | 125.0 | 0.0 |
| 2026-08-17 | Robb Gary Charles | S · Sale | Common Stock | 10000.0 | 116.26 |
| 2026-08-14 | Maduck Sean | M · Exercise / conversion | Common Stock | 3664.0 | 8.27 |
| 2026-08-14 | Maduck Sean | S · Sale | Common Stock | 3664.0 | 114.49 |
| 2026-08-14 | Maduck Sean | M · Exercise / conversion | Stock option (right to buy) | 3664.0 | 0.0 |
| 2026-08-14 | WILSON JAMES N | S · Sale | Common Stock | 3053.0 | 110.49 |
| 2026-08-14 | WILSON JAMES N | S · Sale | Common Stock | 2279.0 | 112.64 |
| 2026-08-14 | WILSON JAMES N | S · Sale | Common Stock | 4668.0 | 111.44 |
| 2026-08-12 | Robb Gary Charles | G · Gift | Common Stock | 3000.0 | 0.0 |
| 2026-08-12 | Robb Gary Charles | G · Gift | Common Stock | 11530.0 | 0.0 |
| 2026-08-12 | Robb Gary Charles | G · Gift | Common Stock | 3000.0 | 0.0 |
| 2026-08-10 | Maduck Sean | M · Exercise / conversion | Common Stock | 1031.0 | 8.27 |
| 2026-08-10 | Maduck Sean | S · Sale | Common Stock | 1031.0 | 114.52 |
| 2026-08-10 | Maduck Sean | M · Exercise / conversion | Stock option (right to buy) | 1031.0 | 0.0 |
| 2026-08-10 | Guyer William | S · Sale | Common Stock | 11530.0 | 113.18 |
| 2026-08-10 | Guyer William | S · Sale | Common Stock | 4770.0 | 114.04 |
| 2026-08-10 | Guyer William | M · Exercise / conversion | Common Stock | 16300.0 | 21.65 |
| 2026-08-10 | Guyer William | M · Exercise / conversion | Stock Option (right to buy) | 16300.0 | 0.0 |
| 2026-08-04 | Guyer William | S · Sale | Common Stock | 3700.0 | 113.12 |
| 2026-08-04 | Guyer William | M · Exercise / conversion | Common Stock | 3700.0 | 21.65 |
| 2026-08-04 | Guyer William | M · Exercise / conversion | Stock Option (right to buy) | 3700.0 | 0.0 |
| 2026-08-03 | Maduck Sean | M · Exercise / conversion | Common Stock | 20305.0 | 8.27 |
| 2026-08-03 | Maduck Sean | S · Sale | Common Stock | 20305.0 | 114.7 |
| 2026-08-03 | Maduck Sean | M · Exercise / conversion | Stock option (right to buy) | 20305.0 | 0.0 |
| 2026-08-03 | Lyon Joseph Douglas | S · Sale | Common Stock | 1540.0 | 114.16 |
| 2026-07-30 | Mokari Atabak | S · Sale | Common Stock | 7089.0 | 116.96 |
| 2026-07-30 | Mokari Atabak | S · Sale | Common Stock | 8267.0 | 117.93 |
| 2026-07-30 | Mokari Atabak | S · Sale | Common Stock | 4783.0 | 118.73 |
| 2026-07-30 | Mokari Atabak | S · Sale | Common Stock | 8103.0 | 119.95 |
| 2026-07-30 | Mokari Atabak | S · Sale | Common Stock | 1001.0 | 120.67 |
| 2026-07-30 | Mokari Atabak | S · Sale | Common Stock | 8956.0 | 106.96 |
| 2026-07-30 | Mokari Atabak | S · Sale | Common Stock | 400.0 | 108.46 |
| 2026-07-30 | Mokari Atabak | S · Sale | Common Stock | 2202.0 | 110.03 |
| 2026-07-30 | Mokari Atabak | S · Sale | Common Stock | 600.0 | 110.95 |
| 2026-07-30 | Mokari Atabak | S · Sale | Common Stock | 4700.0 | 113.18 |
| 2026-07-30 | Mokari Atabak | S · Sale | Common Stock | 15477.0 | 114.96 |
| 2026-07-30 | Mokari Atabak | S · Sale | Common Stock | 14222.0 | 115.87 |
| 2026-07-30 | Mokari Atabak | M · Exercise / conversion | Common Stock | 80000.0 | 23.06 |
| 2026-07-30 | Mokari Atabak | S · Sale | Common Stock | 4200.0 | 105.54 |
| 2026-07-30 | Mokari Atabak | M · Exercise / conversion | Stock option (right to buy) | 80000.0 | 0.0 |
| 2026-07-15 | WILSON JAMES N | S · Sale | Common Stock | 1079.0 | 86.78 |
| 2026-07-15 | WILSON JAMES N | S · Sale | Common Stock | 3969.0 | 87.74 |
Identity & relationships
SEC issuer · 0001088856CORCEPT THERAPEUTICS INC
Search names and former names
View Wikidata identity and references ↗
- Corcept Therapeutics · alias · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $675.04M | $725.06M |
| 2023-12-31 | $482.38M | $533.38M |
| 2022-12-31 | $401.86M | $462.59M |
| 2021-12-31 | $365.98M | $455.00M |
| 2020-12-31 | $353.87M | $460.70M |
| 2019-12-31 | $306.49M | $403.90M |
| 2018-12-31 | $251.25M | $337.11M |
| 2017-12-31 | $159.20M | $218.83M |